Pulmonx (LUNG) Market Capitalization (2020 - 2025)

Pulmonx (LUNG) has reported Market Capitalization for 6 consecutive years, with $92.1 million the latest figure, recorded in Q4 2025.

• On a quarterly basis, Market Capitalization fell 65.91% year-over-year to $92.1 million in Q4 2025; TTM through Dec 2025 was $92.1 million, a 65.91% decrease from a year earlier, with the FY2025 full-year figure at $92.1 million, down 65.91% from the prior year.
• Market Capitalization was $92.1 million for Q4 2025 at Pulmonx, up from $66.8 million in the prior quarter.
• Over five years, Market Capitalization peaked at $1.6 billion in Q1 2021 and troughed at $66.8 million in Q3 2025.
• A 5-year average of $585.9 million and a median of $408.7 million in 2023 frame the typical range for Market Capitalization.
• Across the five-year window, Market Capitalization jumped 68.49% in 2021 and sank 79.59% in 2025, its largest moves.
• Over 5 years, Market Capitalization stood at $1.2 billion in 2021, then plunged by 73.27% to $316.6 million in 2022, then jumped by 55.11% to $491.1 million in 2023, then plunged by 44.99% to $270.1 million in 2024, then plunged by 65.91% to $92.1 million in 2025.
• The last three Market Capitalization figures came in at $92.1 million (Q4 2025), $66.8 million (Q3 2025), and $105.5 million (Q2 2025), per Business Quant data.